Pharmaceutical Technologies

SBIR topic from NSF, solicitation NSF 26-510. Open now. Closes 2027-07-07 (227 days left).

Component (WERX)
—
Agency
NSF
Program / Phase
SBIR
Solicitation #
NSF 26-510
Topic #
PT
Status
Open
Pre-release date
2026-05-22
Open date
2026-05-22
Close date
2027-07-07 · 227 days until close · Add to calendar · See all deadlines
Set-aside
—
NAICS
—
Agency SBIR topic brief

Topic brief

Traditional agency SBIR topic from NSF. Win rates improve when you mirror the solicitation language, show adjacent past performance, and confirm you can meet the close date (2027-07-07).

Agency topic focus: Line-by-line requirements mapping and adjacent past performance win traditional SBIR/STTR topics. Browse NSF awards for context.

Who this is for

  • Firms with past performance in this agency or adjacent tech domain
  • Teams that can evidence requirements line-by-line
  • Companies ready to make a go/no-go within days, not weeks

Capture playbook

  1. Extract SHALL / must requirements (use SAM shred on the solicitation text)
  2. Map each requirement to proof points from past work
  3. Review related awards and named incumbents on this page
  4. Build a Go/No-Go pack and only write if the verdict is GO or MAYBE
  5. Track PT on a pipeline board and set a deadline alert

pWin cues

  • Keyword and technical overlap with prior agency awards
  • Realistic cost and schedule vs median awards in this domain
  • No mandatory set-aside or clearance gap you cannot meet

Watch-outs

  • Bidding topics outside your evidenced domain to 'practice'
  • Ignoring Phase I→II conversion rates in this agency
  • Late start relative to close date

Related awards (competition context)

  • CellDrop Inc
    STTR · Phase II · $999,999 · 2023 · National Science Foundation
  • VERAMORPH LLC
    SBIR · Phase II · $1,000,000 · 2023 · National Science Foundation
  • Lavo Life Sciences LLC
    SBIR · Phase I · $274,990 · 2023 · National Science Foundation
  • INAEDIS, INC
    STTR · Phase I · $275,000 · 2023 · National Science Foundation
  • ENABLE LIFE SCIENCES LLC
    SBIR · Phase I · $274,975 · 2023 · National Science Foundation
  • ALTAY THERAPEUTICS, INC
    SBIR · Phase I · $275,000 · 2023 · National Science Foundation
  • MARWELL BIO INC
    SBIR · Phase I · $274,822 · 2023 · National Science Foundation
  • ROSEBUD BIOSCIENCES INC.
    SBIR · Phase I · $274,829 · 2023 · National Science Foundation

Peer open topics

Topic brief FAQ

How do I research competition on this topic?

Use related awards and competitive intel on this page, plus awardee profiles linked from those awards.

What is a Go/No-Go pack?

A one-click decision pack combining competitive field, conversion signals, related awards, and (Pro) a verdict against your capability.

Where do I find more open topics like this?

Use component and agency filters on /opportunities, or the monthly open-topic digest.

Readiness scorecard Capability match Monthly open-topic digest All topic briefs

Past SBIR/STTR Winners in This Topic Area

Historical federal R&D awardees in adjacent agencies and technology domains — click any firm to inspect their award portfolio or match their capabilities.

  • CellDrop Inc STTR · Phase II · 2023 · National Science Foundation

    The broader impact of this Small Business Technology Transfer (STTR) Phase II project involves continued development of...

  • VERAMORPH LLC SBIR · Phase II · 2023 · National Science Foundation

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project expands the...

+4 more past winners & teaming history in this topic area. Create a free account or enter your email below to unlock full incumbent history and topic alerts.

Go / No-Go decision pack

One-click pack: competitive field, conversion signal, related awards, and (Pro) a full GO / MAYBE / NO-GO verdict against your capability.

Open scorecard Free top-3 capability match

Pro unlocks full Go/No-Go verdicts and named incumbents. Compare plans

Incumbent detector & competitive field

Who already wins work like this, and how hard it is to advance — from 75+ prior awards on record.

75 Incumbents on this topic (PT)
0 Repeat winners in this domain/agency
— Phase I → II conversion
— Median Phase I award

Incumbents (preview)

  • C•••••• — 2 awards
  • C•••••• — 2 awards
  • O•••••• — 2 awards
  • O•••••• — 2 awards
  • T•••••• — 2 awards

Unlock named incumbents and repeat winners with full awardee links — upgrade to Pro or to start.

Description

The Pharmaceutical Technologies topic covers a wide range of technology areas that advance the discovery, formulation, and manufacture of novel drugs, moieties, compounds, products, processes, platforms or services that will improve the selection, quality or price of pharmaceutical and biologic therapies. The Pharmaceutical Technologies topic is not aimed at supporting or conducting clinical trials, clinical efficacy and safety studies, the development of pre-clinical or clinical-stage drug candidates, work on medical devices or schedule I substances, or work performed primarily for regulatory purposes. The NSF SBIR/STTR program no longer supports the development of specific therapeutic molecules. Drug Discovery and Manufacturing are still supported by the program.

Official source: search topic PT (solicitation NSF 26-510) on the agency's SBIR/STTR portal.

Check if your capability fits this topic

Loading teaming suggestions…

Subtopics in Pharmaceutical Technologies (3)